Search

Search Constraints

You searched for: Author/Creator Hiramatsu, Naoki

Search Results

11. Effect of sofosbuvir and velpatasvir therapy on clinical outcome in hepatitis C virus patients with decompensated cirrhosis. Issue 4 (22nd December 2022)

13. Guidelines for the Management of Hepatitis C Virus Infection. Issue 1 (18th January 2013)

14. Hepatocellular carcinoma occurrence does not differ between interferon‐based and interferon‐free treatment with liver histological assessment. Issue 3 (8th January 2020)

15. Human blood dendritic cell antigen 3 (BDCA3)+ dendritic cells are a potent producer of interferon‐λ in response to hepatitis C virus. Issue 5 (14th March 2013)

16. Human blood dendritic cell antigen 3 (BDCA3)+ dendritic cells are a potent producer of interferon‐λ in response to hepatitis C virus12. Issue 5 (14th March 2013)

17. Impact of branched‐chain amino acid supplementation on survival in patients with advanced hepatocellular carcinoma treated with sorafenib: A multicenter retrospective cohort study. Issue 10 (26th January 2016)

18. Impact of ribavirin dosage in chronic hepatitis C patients treated with simeprevir, pegylated interferon plus ribavirin combination therapy. Issue 10 (29th March 2016)

19. Incidence and risk factors of hepatocellular carcinoma change over time in patients with hepatitis C virus infection who achieved sustained virologic response. Issue 5 (6th February 2019)

20. Incidence and risk factors of hepatocellular carcinoma in patients with hepatitis C who achieved a sustained virological response through direct‐acting antiviral agents among the working population in Japan. Issue 6 (18th May 2022)